Literature DB >> 20238219

Transient osteoporosis of the hip: successful treatment with teriparatide.

Gianluigi Fabbriciani1, Matteo Pirro, Maria Rosaria Manfredelli, Massimo Bianchi, Silvio Sivolella, Anna Maria Scarponi, Elmo Mannarino.   

Abstract

A 62-year-old man presented with a 2-month history of increasing pain in the left hip. Magnetic resonance imaging (MRI) showed bone marrow edema (BME) of the left femur, dual energy X-ray absorptiometry (DXA) showed osteopenia at the same level, whereas pelvis X-rays failed to show any objective findings. After ruling out other possible causes of BME such as aseptic osteonecrosis, infectious arthritis, primary or metastatic malignancy, tuberculosis, osteomyelitis, rheumatoid arthritis, and seronegative spondyloarthropathies, a diagnosis of transient osteoporosis of the hip (TOH) was made, and treatment with teriparatide at a daily dose of 20 μg was started and continued for 4 weeks. Disappearance of the symptoms and normalization of MRI were obtained.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20238219     DOI: 10.1007/s00296-010-1404-7

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  15 in total

1.  An investigation of the diagnostic value of bilateral femoral neck bone mineral density measurements.

Authors:  G W Petley; P A Taylor; A J Murrills; E Dennison; G Pearson; C Cooper
Journal:  Osteoporos Int       Date:  2000       Impact factor: 4.507

2.  Transitory demineralization of the hip in pregnancy. A report of three cases.

Authors:  P H CURTISS; W E KINCAID
Journal:  J Bone Joint Surg Am       Date:  1959-10       Impact factor: 5.284

3.  Fracture complicating the bone marrow edema syndrome.

Authors:  Sherry A Guardiano; James Katz; Arnold M Schwartz; Kathleen Brindle; Rudolfo Curiel
Journal:  J Clin Rheumatol       Date:  2004-10       Impact factor: 3.517

4.  Treatment of bone-marrow oedema of the talus with the prostacyclin analogue iloprost. An MRI-controlled investigation of a new method.

Authors:  N Aigner; G Petje; G Steinboeck; W Schneider; C Krasny; F Landsiedl
Journal:  J Bone Joint Surg Br       Date:  2001-08

5.  Histomorphology and bone morphometry of the bone marrow edema syndrome of the hip.

Authors:  H Plenk; S Hofmann; J Eschberger; M Gstettner; J Kramer; W Schneider; A Engel
Journal:  Clin Orthop Relat Res       Date:  1997-01       Impact factor: 4.176

Review 6.  [Transient osteoporosis and osteonecrosis of the femoral head. Risk factors, classification and differential diagnosis].

Authors:  C P Rader
Journal:  Orthopade       Date:  2007-05       Impact factor: 1.087

Review 7.  Bone marrow edema syndrome.

Authors:  Anastasios V Korompilias; Apostolos H Karantanas; Marios G Lykissas; Alexandros E Beris
Journal:  Skeletal Radiol       Date:  2008-07-16       Impact factor: 2.199

Review 8.  Iloprost for the treatment of bone marrow edema in the hindfoot.

Authors:  N Aigner; R Meizer; G Stolz; G Petje; C Krasny; F Landsiedl; G Steinboeck
Journal:  Foot Ankle Clin       Date:  2003-12       Impact factor: 1.653

9.  Increased perfusion of the femoral head in transient bone marrow edema syndrome.

Authors:  Kyung-Hoi Koo; In-Oak Ahn; Hae-Ryong Song; Shin-Yoon Kim; John Paul Jones
Journal:  Clin Orthop Relat Res       Date:  2002-09       Impact factor: 4.176

10.  A subchondral fracture in transient osteoporosis of the hip.

Authors:  Keita Miyanishi; Shigekazu Kaminomachi; Toshihiko Hara; Hironobu Maeda; Hideyuki Watanabe; Atsushi Shimizu; Takehiko Torisu
Journal:  Skeletal Radiol       Date:  2007-01-16       Impact factor: 2.128

View more
  6 in total

Review 1.  Transient osteoporosis of the hip: review of the literature.

Authors:  K Asadipooya; L Graves; L W Greene
Journal:  Osteoporos Int       Date:  2017-03-17       Impact factor: 4.507

2.  [Therapy of bone marrow edema syndrome in the knee with denosumab. Case report].

Authors:  T Geith; W Mutschler; F Berger
Journal:  Unfallchirurg       Date:  2015-03       Impact factor: 1.000

3.  Effectiveness of extracorporeal shock wave therapy in bone marrow edema syndrome of the hip.

Authors:  Cristina d'Agostino; Pietro Romeo; Vito Lavanga; Salvatore Pisani; Valerio Sansone
Journal:  Rheumatol Int       Date:  2014-11       Impact factor: 2.631

4.  Bisphosphonate use and hip fracture epidemiology: ecologic proof from the contrary.

Authors:  Alex Fisher; Jodie Martin; Wichat Srikusalanukul; Michael Davis
Journal:  Clin Interv Aging       Date:  2010-11-19       Impact factor: 4.458

5.  Treatment of transient osteoporosis of the hip with intravenous zoledronate - a case report -.

Authors:  Hyun Seok; Yun Tae Kim; Sang Hyun Kim; Jang Gyu Cha
Journal:  Ann Rehabil Med       Date:  2011-06-30

6.  Outcome of Teriparatide Treatment on Fracture Healing Complications and Symptomatic Bone Marrow Edema in Four Adult Patients With Hypophosphatasia.

Authors:  Tobias Schmidt; Tim Rolvien; Carolin Linke; Nico Maximilian Jandl; Ralf Oheim; Michael Amling; Florian Barvencik
Journal:  JBMR Plus       Date:  2019-08-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.